Miconazole oral gel and drug interactions

British Dental Journal

Volumn 196, Issue 9, 2004, Pages 529-531

  Pemberton, M N ^a   Oliver, R J ^a   Theaker, E D ^a  

^a UNIVERSITY DENTAL HOSPITAL OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; CYCLOSPORIN; FLUCONAZOLE; MICONAZOLE; NEUROLEPTIC AGENT; RAPAMYCIN; THEOPHYLLINE; TSUKUBAENOLIDE; WARFARIN; ANTIFUNGAL AGENT;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; GENERAL PRACTITIONER; HEMATURIA; HUMAN; MALE; TONGUE DISEASE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; GEL; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTICOAGULANTS; ANTIFUNGAL AGENTS; DRUG INTERACTIONS; GELS; HEMATURIA; HUMANS; MALE; MICONAZOLE; MIDDLE AGED; WARFARIN;

EID: 2442687119     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4811224     Document Type: Article

References (21)

1. Pemberton M N, Sloan P, Ariyaratnam S, Thakker N S, Thornhill M H. Derangement of warfarin anticoagulation by miconazole oral gel. Br Dent J 1998; 184: 68-69.
2. O'Reilly R A, Goulart D A, Kunze K L et al. Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects. Clin Pharmacol Ther 1992; 51: 656-667.
3. Watson P G, Lochan B G, Reddind J V. Drug interaction with coumarin derivative anticoagulants. Br Med J 1982; 285: 1045-1046.
4. Meurice J C, Lecomte P, Renard J P, Girard J J. Interaction miconazole et sulfamides hypoglycemiants. Presse Medicale 1983; 12: 1670.
5. Rolan P E, Somogyi A A, Drew M J R, Cobain W G, South D, Bochner F. Phenytoin intoxication during treatment with parental miconazole. Br Med J 1983; 287: 1760.
6. Horton C M, Freeman C D, Nolan P E, Copeland J G. Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature. J Heart Lung Transplant 1992; 11: 1127-1123.
7. Colquhoun M C, Daly M, Stewart P, Beeley L. Interaction between warfarin and miconazole oral gel. Lancet 1987; 1: 695-696.
8. Shenfield G M, Page M. Potentiation of warfarin action by miconozole oral gel. Aust NZ J Med 1991; 21: 928.
9. Pillans P, Woods D J. Interaction between miconazole oral gel (Daktarin) and warfarin. NZ Med J 1996; 109: 346.
10. Evans J, Orme D S, Sedgwick M L, Youngs G R. Treating oral candidiasis: potentially fatal. Br Dent J 1997; 183: 87.
11. Marco M, Guy A J. Retroperitoneal haematoma and small bowel intramural haematoma caused by warfarin and miconazole interaction. Int J Oral Maxillofac Surg 1997; 27: 485.
12. Silingardi M, Ghirarduzzi A, Tincani E, Iorio A, Iori I. Miconazole oral gel potentiates warfarin anticoagulant activity. Thromb Haemost 2000; 83: 794-795.
13. Ogard C G, Vestergaard H. Interaction between warfarin and miconozole oral gel. Ugeskr Laeger 2000; 162: 5511.
14. Thirion D J G, Zanetti L A F. Potentiation of warfarin's hypoprothrombinemic effect with miconazole vaginal suppositories. Pharmacotherapy 2000; 20: 98-99.
15. Murty M. Miconazole-warfarin interaction: increased INR. CMAJ 2001; 165: 81-82.
16. US Food and Drug Administration (FDA). FDA talk paper: Miconazole Vaginal cream and Suppositories safety information. Rockville: FDA, 2001.
17. Devaraj A, O'Beirne J P, Veasey R, Dunk A A. Interaction between warfarin and topical miconazole cream. Br Med J 2002; 325: 77.
18. Marotel C, Cerisay D, Vasseur P, Rouvier B, Chabanne J P. Potentialisation des effets de l'acenocoumarol par le gel buccal de miconazole. Paris Medicale 1986; 15: 1684-1685.
19. Ducroix J P, Small A, Sevenet F, Andrejak M, Baillet J. Haematome oesophagien secondaire a une potentialisation des effets de l'acenocoumarol par le gel buccal de miconazole. Rev Med Interne 1989; 42: 412-413.
20. Ortin M, Olalla J I, Muruzabal M J, Peralta F G, Gutierrez M A. Miconazole oral gel enhances acenocoumarol anticoagulant activity: a report of three cases. Ann Pharmacother 1999; 33: 175-177.
21. British National Formulary. 43. London: BMA, RPS, 2002.